Tempus is an artificial intelligence company developing new treatment plans for patients with cancer by collecting molecular data. The information is then made available to physicians through an operating system that allows doctors to make data-driven treatment decisions with their patients. Tempus was founded by Eric Lefkosky, the co-founder of Groupon, in 2015.
Tempus uses genomic tests to analyze DNA, RNA, and proteomic data to understand a patient's tumor at the molecular level to identify treatment options that are patient-centric. The Tempus platform analyzes thousands of clinical and molecular data points, connecting physicians with up-to-date treatment options and insights for patients based on their molecular profile.
Tempus launched a diagnostic polymerase chain reaction (PCR) test for COVID-19. Tempus' CAP-accredited/CLIA-certified labs in Chicago and Atlanta are supporting the acceleration of testing in the U.S, and expect to test approximately 12,000 patients daily across both labs, with the ability to scale further if needed.
Tempus offers an on-demand virtual case review system that provides clinical support to physicians and care teams in a timely manner. Tempus' Medical Affairs team is available to answer patient report questions in real-time in a secure portal. In addition, Tempus now offers a variety of telehealth support services specific to COVID-19 if needed.
Tempus launched a large research collaboration to structure data for up to 50,000 COVID-19 positive patients. Tempus is partnering with providers to collect data on COVID-19 patients, which Tempus is structuring and de-identifying without cost. In addition, Tempus expects to perform full transcriptomic profiling of approximately 10,000 patients within the cohort. All data will be shared with all participating institutions without restriction.
Tempus acquired AKESOgen on Dec 11, 2019.
Chief of People Officer
Founder & CEO
Chief Administrative and Legal officer
Chief Medical Officer
Chief of Operations Officer
Chief Technical Officer
Chief Financial Officer
Chicago precision medicine startup Tempus nabs $200M for expansion - MedCity News
May 30, 2019
Chicago's Tempus Labs Signs 5 Year Lease in Manhattan | CoStar
June 15, 2020
Following $110M fundraise, Tempus reveals mobile app to give doctors access to clinical data - MedCity News
September 19, 2018
Health Data Startup Tempus Accused of Poaching Top Executive
December 4, 2019
Lefkofsky's Tempus raises $100 million to expand beyond cancer
March 13, 2020
Tempus Acquires Commercial Lab, Precision Medicine Services Provider Akesogen
December 13, 2019
Tempus closed $200 million funding round to reach $3 billion valuation - Business Insider
May 31, 2019
Tempus: Health start-up backed by Groupon co-founder joins the fight against Covid-19
June 17, 2020
Documentaries, videos and podcasts
- CompanyA company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.
- Unicorn (finance)A privately held startup company with a valuation above $1 billion.
- Cluster: BiotechnologyA cluster of topics related to biotechnology.